뒤로
Frontage Holdings Corporation(FGHQF) 가격
FGHQF 주가 차트
FGHQF 수입
Frontage Holdings Corporation
$0.14
0%
$0
종가: Jan 28, 16:00:00 GMT-5
$0.14
0%
$0
애프터마켓: Jan 28, 20:00:00 GMT-5
Earnings FAQ
FGHQF의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Frontage Holdings Corporation FGHQF의 지난 분기 매출 실적은 어땠나요?
Frontage Holdings Corporation의 매출 추정치는 얼마인가요?
Frontage Holdings Corporation의 수익 품질 점수는 얼마인가요?
Frontage Holdings Corporation는 언제 수익을 보고하나요?
Frontage Holdings Corporation의 예상 수익은 얼마인가요?
Frontage Holdings Corporation은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.1498
시가
$0.1498
일일 범위
$0.1498 - $0.1498
52주 범위
$0.101 - $0.1498
거래량
130
평균 거래량
0
EPS(TTM)
0.00
배당수익률
--
시가총액
$303.7M
FRONTAGE HOLDINGS CORP란 무엇인가요?
Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. The company is headquartered in Exton, Pennsylvania and currently employs 1,540 full-time employees. The company went IPO on 2019-05-30. The company provides laboratory and related services to pharmaceutical and agrochemical companies, as well as bioequivalence clinical and chemical services. The firm has two main divisions: Global Laboratory Services and Global Drug Discovery & Development Services. The Global Laboratory Services division offers laboratory testing support for clients involved in drug development. The Global Drug Discovery & Development Services division includes Drug Development Unit, the Drug Discovery Unit, and the Pharmaceutical Product Development Unit. Its Global Laboratory Services encompass regulated and non-regulated bioanalysis (both small and large molecules), biomarkers, genomics, manufacturing and controls analytical testing, and central laboratory services. The Drug Development Unit includes drug metabolism and pharmacokinetics, Safety and Toxicology. The firm's segments include North America and Europe and PRC.